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Summary.-Antisera to extracts of a variety of bronchogenic carcinoma were
raised in rabbits and extensively absorbed with immunoadsorbents prepared with
normal lung extracts cyanogen bromide linked to Sepharose 4B, and glutaraldehyde
insolubilized normal lung extracts. The antisera were tested by immunodiffusion
against a panel of extracts from a variety of bronchogenic carcinoma, foetal lung
extracts and pools of normal lung extracts. The results indicate that two distinct
antigenic components are associated with bronchogenic carcinoma; one which is
present in a high percentage of the tumour extracts tested and appears to have
partial identity with a foetal lung component, and one (or more) which is not foetal
and appears to have higher cross-reactivity (but not exclusively) with tumours ofthe
same pathological type. Attempts to detect either antibody or antigens relating to
these components in the serum of patients with bronchogenic carcinoma by these
techniques were unsuccessful. The foetal cross-reacting component was neither
carcinoembryonic antigen nor cxl-foetoprotein.
THERE HAVE BEEN a number of
reports indicating that extracts from a
variety of lung carcinomata contain anti-
genic components not demonstrable in
equivalent extracts ofnormal human lung.
Yachi and his co-workers (Yachi et al.,
1968) found that an ammonium sulphate
(5000 saturated) cut of tumour extracts
contained 2 distinct antigenic components,
one of which cross-reacted with a foetal
antigen and one which appeared to be
specific for tumour extracts. Neither
antigenic component was demonstrable in
all extracts tested. More recently, Mohr
et al. (1974), using supernatants from
tissue cultures of alveolar cell carcinoma
as their antigenic preparation and
absorbed sheep antiserum, demonstrated a
common tumour specific antigen by
immunodiffusion with the heterologous
antiserum and cell culture supernatants as
well as with serum from patients with
alveolar cell carcinoma and, in some
instances, with Hodgkin's disease. Sega
et al. (1974) have reported the presence of
tumour specific antigenic material present
in a pooled extract of a variety of lung
carcinomata. Similar observations have
been made by others (Okada and Ikeda,
1970).
Although, to date, reports on the
demonstration of tumour associated anti-
gens in human bronchogenic carcinoma
are not extensive, the indication in all the
evidence so far published is that some
common antigens may be present in this
rather heterogeneous group of neoplasms.
The present study was undertaken in an
attempt to extend the body of knowledge
to a point where some general conclusions
might be drawn. Heterologous absorbed
rabbit antisera to individual tumour
extracts of a variety of pathological
types of tumours were tested against a
panel of 50 different tumour extracts,
foetal extracts and extracts of eitherTUMOUR ASSOCIATED ANTIGENS IN BRONCHOGENIC CARCINOMA
pooled or individual normal human lung
tissues. The findings are reported in this
paper.
MATERIALS AND METHODS
Extraction methods.-All tissues were
treated in essentially the same way.
Tumours were obtained from either post
mortem specimens or from surgical pneu-
monectomies; one tumour (C-24) was
obtained as a metastatic tumour in the liver.
They were prepared by excising all apparently
normal tissue before grinding and extraction
of the tumour. Normal lung preparations
were obtained as post mortem specimens
from patients dying from non-malignant
disease. Foetal lungs were removed from
12-18 week saline induced aborted foetuses.
Tissues were teased to separate individual
cells and passed through a tissue grinder.
The tissue volume was measured and 6 times
the volume of 3 -5 mol/l KCl was added,
bringing the final salt concentration to
3 -0 mol/l. Extractions were carried out
with gentle agitation at 4°C for 18 h, after
which the cell debris wasremovedbycentrifu-
gation at 16,000 g for 90 min. Cell extracts
were dialysed exhaustively with several chan-
ges of phosphate buffered saline (PBS, 0-15
mol/l, pH 7-2), after which they were again
centrifuged at 16,000 g for 90 min. The ex-
tracts were sterilized by Millipore filtration
and stored at -20°C.
Protein concentrations of the extracts
were estimated by the standard Lowry
technique. Tumour extracts contained
between 5-0 and 15-0 mg/ml. Many of the
normal extracts were maintained at consider-
ably higher protein concentrations (30 -0
mg/ml) in order to minimize the possibility of
regarding relatively small quantitative
differences in cell components as tumour
specific materials.
Anti8era.-Randomly bred albino rabbits
were immunized by 8 weekly injections of
tumour extract. Dose levels were at 7-5 mg
ofprotein in 1 0 ml of50% complete Freund's
adjuvant, administered in 5 locations-4
intramuscularly in each limb and one intra-
peritoneally. Animals were test bled 10
days after the last injection by the ear vein
and their serum tested by immunodiffusion
with the homologous extract. If the anti-
serum, after immunoadsorption, failed to
detect tumour associated material, further
immunizations were carried out. Final
bleeding was carried out by cardiac puncture.
Serum was stored at -20TC.
Immunoabsorption.-An immunoadsor-
bent was prepared by binding a pool of 8
normal lung extracts to Sepharose 413 with
cyanogen bromide. The technique has been
described in detail previously (Watson,
Smith and Levy, 1974). The only changes in
the basic technique was that the " anti-
normal" antibody were eluted fronm the
columns with Sorensen's buffer (glvcine-HCl,
pH 2-6), and the columns were regenerated
with starting buffer.
Before the eluted anti-tumour antibody
was concentrated, it was further absorbed on
a glutaraldehyde insolubilized preparation of
normal lung extract. This immunoadsorbent
was prepared according to the method of
Avrameas and Ternynck (1969) with the
following modification: Normal lung
extracts to be treated were dialysed against
0-1 mol/l acetate buffer pH 5-0 at 4°C
overnight. Glutaraldehyde at a concen-
tration of 25% was added slowly, with
stirring, to a final concentration of 50 mg/
100 mg protein. The mixture was stirred at
room temperature for 4 h, after which it was
allowed to react for 18 h at 4TC. The
mixture was diluted 1: 5 with PBS and
centrifuged at 2000 g for 15 min at 4TC.
The pellet was homogenized and washed
again with PBS, after which it was again
homogenized and washed with 0-1 mol/l
glycine-HCl buffer at 2-8. The insolubilized
material was washed a further 2 times with
PBS, homogenized and stored in PBS at 4°C.
Absorption of the anti-tumour antiserum
was carried out using a 1 : 1 volume of
antiserum and insoluble normal extract.
Absorption was carried out at 4"C for 18 h,
after which the insoluble material was
removed by centrifugation. The super-
natant was concentrated by either ultra-
filtration on an XM 100 A ultrafiltration
membrane (Amicon) or by precipitation with
50% saturated (NH4)2SO4. The glutaralde-
hyde insolubilized immunoadsorbents were
not re-used.
Immunodiffusion.-Immunodiffusion was
carried out on glass slides using 0-85%
Jonagar and a template for 6 samples around
a centre well. Antiserum and extracts were
added as 50 ,u samples and diffusions were
developed at 4"C for 4 days in a humidified
chamber. In some instances, titrations of
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extracts were run in which sample sizes varied
between 10 and 100 pd, with volumes made
up with PBS. Slides were washed in PBS for
3 days, dried, stained with Amido black and
destained in 5% acetic acid for 30 min.
Each series of 6 contained one sample of
homologous extract and at least one normal
or foetal extract.
Tests for carcinoombryonic antigen (CEA)
and cxl-foetoprotein.-Assays for CEA in
tumour extracts in antisera were carried out
by the Division of Nuclear Medicine, Van-
couver General Hospital, using the CEA-
Roche Test Kit.
Absorbed, highly specific goat antiserum
to a1-foetoprotein was donated by Dr S. 0.
Freedman, McGill University School of
Medicine. Tests with this antiserum were
carried out by immunodiffusion using both
amniotic fluid and foetal lung extracts as
positive controls.
RESULTS
A total of 15 absorbed heteroantisera
were prepared in rabbits against extracts
of individual tumour extracts of a variety
of pathologies. These antisera were
tested individually against a panel of 45
tumour extracts, 4 different normal lung
extracts, one consisting of a pool of 8
normal lung extracts (referred to as
normal pool), and 3 consisting of indivi-
dual extracts and 2 foetal lung extracts
each consisting of a pool of 8 foetal lungs.
The immunodiffusion results are presented
in Tables I-VI, and are broken down
according to tumour pathology. The
designation (i) used in these Tables
indicates the presence of an immuno-
diffusion band on the inner region near the
antiserum well. It was distinct from
other outer immunoprecipitin lines (see
below). Normal lung extracts, foetal
lung extracts and normal serum samples
were tested as controls. The results are
presented in Table V. The percentage of
cross-reactivity in relation to the path-
ology and the type of antiserum are
shown in Table VI. All positive reactions
recorded indicate positive immuno-
diffusion bands not seen in any of the
normal extracts tested.
It can be seen that there appears to be
some correlation between tumour path-
ology and the degree of cross-reactivity as
demonstrated by this technique. A high
degree of cross-reactivity was also seen
between squamous cell carcinoma and
anaplastic tumours. Some antisera were
considerably more potent in the pro-
duction of antibodies which were
apparently tumour specific. It is not
TABLE I.-Results of Immunodiffusion with Absorbed Antisera to Tumour Extracts of
Various Pathological Types with Individual Extractsfrom Squamous Cell Carcinomata
Antigen extract
(Squamous
cell
carcinoma)
C-1
C-6
C-53
C-60
C-61
C-63
C-66
C-69
C-71
C-74
C-75
C-76
C-79
C-87
C-90
C-93
C-94
Squamous cell carcinoma
-6 0-53 0A57 063 66071
C-6 C-53 C-57 C-63 C-66 C-71
+ -
+ -
+ (i)
+ + + (i) + (i) -
- + + (i)
+ + (iW
+ + (i) +(i)
+ - + ±(i) + (i)
++ (i) + (i)
__ + (i + (iW
+ + + (i) -
+ + (i) -
+ + + (i - -
+ (i) +
+ + (i)- _
+ -t (i) - -
+ + (i) - _
+F + (i) - -
Adeno- Oat cell Alveolar
carcinoma Anaplastic carcinoma carcinoma carcinoma
C-24 C-26 C-41 C-46 C-62 C-67 C-40 C-78 C-30
+ _-_ _ + (i)
_ _ ±_ + (i)
_+ (i)
-+ (i)
+
_ + (i)
+ + (i)
- + (i)
- + (i)
- + (i)
- -1 (i)
- + (i)
- + (i)
+ (i)
+ (i) _
+ (i) -
+ (i) -
+ -
+ (i) -
+ (i) -_
+
+
+ -
+
+
+
+
+
+
+
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TABLE JJ.-Immunodiffusion Results using Absorbed Antisera to Tumour Extracts of
Various Pathological Types with Individual Extractsfrom Adenocarcinomata
Absorbed antisera
Antigen Adeno- Oat cell Alveolar
extract Squamous cell carcinoma carcinoma Anaplastic carcinoma carcinoma carcinoma
(Adeno-
carcinoma) C-6 C-53 C-57 C-63 C-66 C-71 C-24 C-26 C-41 C-46 C-62 C-67 C-40 C-78 C-30
C-3 - - -
C-5 - _ _
C-24 - - - - + + (i) +
C-26 - - - - + + +
C-36 - _ _ + (i)- + + +(i) + +
C-45 + + (i) +
C-58 + (i) _ _
C-85 + (i) +(i) - + (i) - - +(i)
C-88 - +(i) - +(i) - +(i)
TABLE IIJ.-Immunodiffusion Results using Absorbed Antisera to Tumcur Extracts of
Various Pathological Types with Individual Extracts from Anaplastic and Oat Cell
Carcinomata
Absorbed antisera
Antigen Adeno- Oat cell Alveolar
extract Squamous cell carcinoma carcinoma Anaplastic carcinoma carcinoma carcinoma
Anaplastic
carcinoma C-6 C-53 C-57 C-63 C-66 C-71 C-24 C-26 C-41 C-46 C-62 C-67 C-40 C-78 C-30
C-41 + - + (i)+ + + - ++(i)+ (i) - - -
C-46 + - + (i) - + (i) + _ _
C-56 + + + (i) + - + (i) + (i) -
C-62 + + +(i) + ) - +(+i(i)
C-67 - - + (i) + + - + (i)
C-92 - - +(i) - - - - - -
Oat cell
carcinoma
C-40 - - - - - - - + (i) + -
C-64 - + - - - + (i) - - - +
C-65 - - + (i) + (i) -+(i)
C-70 - _ + (i) + (i) - - + (i) - + (i) + +
C-72 + + +(i) + (i) - - + ()
C-78 + +(i) - - _ + +(i) -
TABLE IV.-Immunodiffusion Results Using Absorbed Antisera to Tumour Extracts of
Various Pathological Types with Individual Extracts from Tumours of Miscellaneous
Pathology all Arisingfrom the Lung
Absorbed antisera
Adeno- Oat cell Alveolar
Squamous cell carcinoma carcinoma Anaplastic carcinoma carcinoma carcinoma
Extract C-6 C-53 C-57 C-63 C-66 C-71 C-24 C-26 C-41 C-46 C-62 C-67 C-40 C-78 C-30
Alveolar
carcinoma
C-30 - + (i)- - +- - d + d- - +
C-81 + +(i) - - - +(i) - -
Mixed squamous
adenocarcinoma
C-82 - + (i) + () +(i) - - -
Carcinoid
C-4 - + (i) -- - - - - -
Rhabdomyo-
sarcoma
C-77 + + +(i)- -+(i) - + +
Metastatic
squamous
C-57 + ++(i) + (i) - - (i)- - +(i) - _
Mesothelioma
C-54 - - - + (i) - - + (i) - - + 7(i) - - \-l IXIR. D. WATSON, A. G. SMITH AND J. G. LEVY
TABLE V. Immrbunodiffusion Results using Absorbed Antisera to Tumour Extracts of
Various Pathological Types with both Individual and Pooled Extracts from Normal
Adult Lung, Foetal Lung and Serum Samples from Normal Individuals
Absorbed antisera
Adeno- Oat cell Alveolar
Squamous cell carcinoma carcinoma Anaplastic carcinoma carcinoma carcinoma ,~~~~~~~~~ -T ,-A
Extract C-6 C-53 C-57 C-63 C-66 C-71 C-24 C-26 C-41 C-46 C-62 C-67 C-40 C-78 C-30
N-25
N-50
N-83
N-pool*
F-48t + (i) + (i)
Serum 1I
Serum 2
* A pooled preparation of 8 individual normal lung specimens.
t A pooled preparation of 8 individual foetal lung specimens.
t Sera were taken from normal individuals and tested for the presence ofantigen.
TABLE VI. A Summary of Data Presented in Tables I-IV showing the Percentage of
Positive Results between Pathological Groupings of Antisera and Tumour Extracts
Anti-
squamous
(6)
Anti-adeno-
carcinoma
(2)
Aniti-
anaplastic
carcinoma (4)
Anti-oat
cell carcinoma
(2)
Anti-
alveolar
carcinoma (1)
Extracts --,>
(number) Total + (i) Total + (i) Total + (i) Total + (i) Total + (i)
Squamous (17) 46-8 23-4 4-9 0 41-9 33 9 28-1 0 18-7 0
Adeno-
carcinoma (9) 11-5 9-6 25-0 0 27-7 19-5 0 0 33-0 0
Anaplastic (6) 42-8 17- 1 12-5 0 45-8 33-3 0 0 0
Oat cell (6) 32-3 20-6 0 0 30-4 26- 1 33-3 12-5 33-3 0
Alveolar (2) 27-2 18-2 33-3 0 37-5 12-5 25-0 0 50.0 0
The data are further broken down to indicate what percentage ofpositive cross-reactions can be attributed
to the inner immunodiffusion band which shows partial identity with foetal lung extract F-48.
clear whether this is applicable to indivi-
dual animal differences or to differences in
tumour extracts.
It was clear that at least 2 distinct
types of tumour associated material were
detectable by these procedures. One
type formed a distinct clear band close to
the antigen well, and cross-reactivity with
other extracts did not occur at a high
frequency. Typical examples are shown
in Fig. 1. The second type, when
present, formed a band relatively close to
the antiserum well and cross-reactivity
with other tumour extracts was at a high
frequency (see antisera for C-57 and C-41).
This band is designated in the Tables as
+ (i). While the outer bands at no time
showed identity with either normal or
foetal extracts, the inner band in some
instances showed partial identity with one
foetal extract (F-48). This is illustrated
in Fig. 2 and 3. Some extracts dem-
onstrated the presence of both inner and
outer bands, indicating that 2 separate
antigens were responsible (Fig. 4).
The possibility was considered that the
inner band could be identified as carcino-
embryonic antigen (CEA). Tests run on
extracts which were either positive or
negative for the presence of this reactive
material showed that no correlation
existed between CEA levels and the
presence of the inner precipitin band. A
large selection of tumour extracts as well
as normal lung extracts were tested for the
presence of CEA by the standard CEA-
Roche Test Kit. Many of the tumour
extracts contained appreciable levels of
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FIm. 1. Immunodiffusion results using absorbed antiserum to C-62 against 6 extracts designated as
follows: 1, C-62; 2, C-77; 3, C-78; 4, normal pool; 5, C-93; 6, C-94. While strong precipitin lines
developed against the extracts in wells 2 and 6, no bands formed against the homologous extract.
The protein concentrations per well for each extract tested were as follows: C-62, 0-33 mg; C-77,
0-39 mg; C-78, 0-33 mg; normal pool, 145 mg; C-93, 0-41 mg; C-94, 0-31 mg.
FIG. 2.-Immunodiffusion results using absorbed antiserum to C-41 against 6 extracts designated as
follows: 1, C-41; 2, C-65; 3, C-70; 4, F-48; 5, C-62; 6, C-85. The inner band seen shows partial
identity with the foetal extract, F-48. The protein concentrations per well for each extract tested
were as follows: C-41, 1-05 mg; C-65, 0-32 mg; C-70, 0-28 mg; F-48, 0-72 mg; C-62, 0 33 mg;
C-85, 0* 27 mg.
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FIG. 3.-Immunodiffusion results using a poorly absorbed antiserum to C-41 against 6 extracts
designated as follows: 1, C-57; 2, C-66; 3, C-67; 4, normal pool; 5, C-68; 6, C-69. The inner
precipitin line seen in all the tumour extracts is not seen in the normal extract. The protein
concentrations per well for each extract tested were as follows: C-57, 0 43 mg; C-66, 0 28 mg;
C-67,0-24 mg; normal pool, 1-45 mg; C-68,0 43 mg; C-69,0-58 mg.
FIG. 4.-Immunodiffusion results using absorbed antiserum to C-78 against 6 extracts designated as
follows: 1, C-78; 2, C-77; 3, C-78; 4, normal pool; 5, C-93; 6, C-94. Note the occurrence of both an
inner and outer precipitin line in well 2. Protein concentrations per well for each extract tested
were as follows: C-78, 0 33 mg; C-77, 0 39 mg; C-78, 0-16 mg; normal pool, 1-45 mg; C-93,
0-41 mg; C-94, 0 31 mg.
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Fic'. 5.-Immunodiffusion results using anti-oc1-foetoprotein at a I: 3 dilution against 6 extracts
designated as follows: 1, C-53; 2, normal pool; 3, F-48; 4, C-40; 5, C-3; 6, C-57. The protein
concentrations per well for each extract tested were as follows: C-53, 1 * 10 mg; normal pool 1 * 45 mg;
F-48 (foetal extract), 0-72 mg; C-40, 19 -90 mg; C-3, 0-63 mg; C-57, 0-86 mg.
CEA (>100 ng/ml) whereas others con-
tained very low levels. Because the
assayed levels of CEA did not correlate in
any way with those extracts showing the
presence ofthe inner band, it was felt that
it was unlikely that the antigen in this
instance was CEA. Similarly, radio-
immunoassays run on antisera showing the
presence of antibody specific for this
inner band indicated that no detecuable
levels of anti-CEA were present. This
combined evidence led us to conclude that
this component could not be CEA.
The possibility that this inner band
was related to oc1-foetoprotein was also
investigated. Absorbed goat anti-oxl-
foetoprotein was run in immunodiffusion
with foetal extracts, tumour extracts and
normal lung extracts. Strong positive
precipitin lines developed between the
foetal extracts and the antiserum but no
detectable reaction was observed with
either normal lung or tumour extracts. A
representative set of results is shown in
Fig. 5. Tumour extracts were chosen
which either showed the presence of the
inner precipitin line (C-53, C-40 and C-57)
or did not (C-3). In all instances no
immunological reactivity was seen with
any tumour extract with undiluted goat
anti-a1-foetoprotein, while this antiserum
at diltutions of 1: 10 reacted strongly with
foetal extracts.
The serum from patienits witlh eithier
metastatic bronchogenic carcinoma or
patients following surgery for broncho-
genic carcinoma was tested by immuno-
diffusion with either tumour extracts
(homologous or heterologous) or the
absorbed antiserum, in an attempt to
detect either circulating antigen or specific
anti-tumour antibody. No antigen or
antibody was detectable in any instance.
Normal sera tested in the same way were
also negative (Table VT).
D)ISCUSSION
It is extremely difficult to assess
critically the data presented here. If the
most naive interpretation is to be used, it
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would appear that bronchogenic carci-
noma cells may contain at least 2 compo-
nents which are antigenic in a xenogeneic
species and which are either absent or
present in very low concentrations in
normal lung tissue. One of the compo-
nents appears to be cross-reactive but not
identical to a component present in the
extracts of foetal lung. This component
is neither CEA nor ax-1foetoportein. When
antibodies to this component were present
in appreciable amounts in absorbed anti-
sera, the level of cross-reactivity between
tumour extracts was found to be very
extensive (see antisera C-41, C-57 and
C-62 in particular). The reaction of this
antibody with foetal extracts, on the
other hand, was very weak and not
detectable in most instances, even though
the protein concentrations in the foetal
extracts were generally higher than in the
tumour extracts. This would imply that
this constituent is not present in high
concentrations in foetal lung. The nature
of this component requires considerably
more investigation before further con-
clusions can be drawn. It is interesting to
note that earlier investigators (Yachi et al.,
1968) made the observation that a high
percentage of the bronchogenic carcinoma
extracts that they were studying con-
tained a component which shared partial
identity with a foetal antigen.
The second antigenic component(s)
observed in this study is impossible to
evaluate at this time. Whether or not the
degree of cross-reactivity observed with
antisera and the tumour extract panel is
reliable cannot be assessed. It is still not
clear whether all the outer precipitin
bands observed are identical antigens even
for an individual antiserum. It is
possible that a greater degree of cross-
reactivity may exist than was observed
here since the methods used here for
antigen detection are not very sensitive.
This is apparent from our not infrequent
observation that an antiserum would
show no specific precipitation with the
homologous antigen but would show
significant precipitation with a hetero-
logous tumour extract (see Fig. 1). The
limit for detection of antigenic materials
by the immunodiffusion technique used
here is in the region of 2 0 ,tg/ml. It is
possible that hyperimmunized rabbits
could mount a considerable immune
response to components in the extract
present in concentrations lower than this
level, and thus give rise to antisera which
demonstrate tumour associated antigens
in heterologous extracts (which contained
higher concentrations of the antigen) but
fail to do so with the homologous extract.
It is also important to recognize the
possibility that bacterial or viral con-
taminating antigens may be responsible
for the formation of these bands since
tumour specimens taken from the lung are
invariably heavily contaminated.
The control tests included 3 individual
extracts from lung tissue taken at post
mortem from patients dying from non-
malignant causes, as well as a pooled
extract from 8 other individuals. In no
instance did these extracts demonstrate
positive immunodiffusion bands with the
absorbed antisera which were reported as
positive in this study. It is clearly
impossible to ascertain at this point
whether these data indicate qualitative
or quantitative differences between lung
tumour tissues and normal lung tissue.
Until these antigenic components have
been purified and high titre monospecific
antiserum prepared to them, these un-
certainties cannot be clarified. Pre-
liminary studies indicate that such an
undertaking is possible and work is
currently under way which addresses itself
to these issues.
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